HOME >> BIOLOGY >> NEWS
Virtual reality training tool pits emergency rescue teams against computerized terrorist attack

ALBUQUERQUE, N.M.-- In the emergencies of tomorrow--when rescue personnel may need to triage and treat mass casualties following release of a nerve agent in a shopping mall, theme park, or subway, for instance--there will be no second chances. Rescuers who become victims of a terrorist attack can't save lives. Soon emergency medical technicians (EMTs) and firefighters may be able to practice responding to such attacks using a virtual reality (VR) training tool under development at the Department of Energy's Sandia National Laboratories. Sandia computer scientists have combined seven years of virtual reality research into BioSimMER, a VR application that immerses first responders in a 3-D computer-simulated setting--a small airport in which a biological warfare agent has been dispersed following a terrorist bombing. Simulated casualties with a variety of symptoms are found throughout the airport.

BioSimMER can help emergency personnel make better decisions if ever they are called on to respond in a real chem-bio attack, says project leader Sharon Stansfield.

"With virtual reality, you can practice over and over again, like in a video game," she says. "You make mistakes, you learn. If someone dies, you can hit the reset button."

Saving "cyber casualties"

The computer simulation engages the rescuer's eyes, ears, and decision-making abilities through goggles that display the scene's images. The rescuer wears sensors on the arms, legs, and waist, allowing the player's motions to be fed back into the simulation.

The researchers worked closely with Dr. Annette Sobel, a Sandia physician and researcher, to create "cyber casualties" with realistic symptoms and real-time changes in their conditions. One virtual casualty has a visible chest wound. Another has symptoms that indicate head trauma. Another suffers from inhalation of Staphylococcal enterotoxin B (SEB), the airborne bio agent used in the simulation. And a fourth appears to exhibit the
'"/>

Contact: John German
jdgerma@sandia.gov
505-844-5199
DOE/Sandia National Laboratories
23-Sep-1999


Page: 1 2 3

Related biology news :

1. Virtual counselor supplements traditional genetic counseling
2. European Virtual Institute for Genome Annotation receives 12 million Euro
3. Gastrointestinal specialists comment on new study on Virtual colonoscopy
4. Virtual cells help unravel cell motion
5. Virtual lung models every breath you take - and its impact
6. Virtual reality tool quantifies physics of a doctors touch
7. University-Industry-Government Institute Will Study Pollution Control Chemistry In A Unique Virtual Collaboration
8. DFG To Set Up 32 New Postgraduate Research Groups - First "Virtual Research Group"
9. Microsurgery Made More Accurate With Virtual Measuring Tool
10. Robots, Virtual Reality & Other "Smart" Tools Soon Will Help Physicians Heal Patients
11. From science fiction to reality: Nanomedicine brings fresh hope to the medical world

Post Your Comments:
(Date:5/20/2013)... resistant to the antibiotic colistin are also commonly ... body, according to a study in mBio ... Society for Microbiology. Cross-resistance to colistin and host ... body against bacterial attack, could mean that patients ... with a crippled immune response. Colistin is a ...
(Date:5/20/2013)... Science Foundation (NSF) planning grant will help establish the ... program of the University of Illinois at Urbana-Champaign and ... will be devoted to research in drying moist, porous ... and paper products; chemical products; textiles; and biopharmaceuticals," said ... science and human nutrition and the Illinois site director. ...
(Date:5/19/2013)... strain of electricity-producing bacteria that can grow using hydrogen ... as its sole source of carbon. Researchers at ... the 113th General Meeting of the American Society for ... production solely on hydrogen," says Amit Kumar, a researcher ... part of the Lovley Lab Group at the university. ...
Breaking Biology News(10 mins):Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3NSF approves planning grant for Center for Advanced Research in Drying 2
(Date:5/21/2013)... Raleigh, NC (PRWEB) May 21, 2013 ... and financial services company for clinical trials, announced ... Aggregate Spend Solutions, LLC. Clinverse’s ClinPay® FLS ... automated investigator payment process. SpendMD ™, ... only complete solution for tracking and reporting transfer ...
(Date:5/21/2013)... , May 21, 2013 According ... Research ( http://www.transparencymarketresearch.com ) "Biochip Products and Services Market ... - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," ... 2011 and is expected to grow at a CAGR ... estimated value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... 21, 2013 Many have long discussed ... to acne. Recently physicians from Clinical Psychiatry.com ... on the skin, and suggested using hypnotherapy ... chemicals produced from stress that cause acne. , Doctors ... feelings acne brings about, stress causes changes in the ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
Breaking Biology Technology:Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: